Trial Profile
Tolerance of Triflusal in Patients With Immediate Cutaneous Hypersensitivity to Nonsteroidal AntiinflammatoryDrugs
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Triflusal (Primary)
- Indications Angioedema; Urticaria
- Focus Therapeutic Use
- 17 Dec 2015 New trial record